James Ahern

Managing Partner, Laidlaw & Company (UK)

[James Ahern @JamesPAhern]

Private investment in medical research is necessary and I am proud of the work we do to fight diseases and treat so many ailments. Read my perspective at https://t.co/Rs7Gq4JKgg

[James Ahern @JamesPAhern]

I am proud to report that AerWave Medical is beginning human trials as we seek to find relief for those suffering from lung-related ailments including COPD, asthma, and more.

https://t.co/0Uq1ZF1CTB

[James Ahern @JamesPAhern]

Thank you to .@CrainsNewYork for naming me to their list of Notable Leaders in Finance 2024. https://t.co/NpGuebj56L

[James Ahern @JamesPAhern]

Congrats to the Laidlaw Capital Markets team for todays 50 million dollar transaction for Biomx.

Led by Deerfield, and filled in with a tremendous set of investors, a credit to the outreach effort by the team.

https://t.co/KYswnQGGPN

[James Ahern @JamesPAhern]

3/3 Congratulations and thank you to the entire Viking team, their recent top-line results from the Phase 2 VENTURE trial of dual GLP-1/GIP receptor agonist VK2735 in patients with obesity has grown the company to an $8B market cap today.

[James Ahern @JamesPAhern]

1/3 Laidlaw Capital Markets is pleased to have Co-Managed Viking Therapeutics' (NasdaqCM: VKTX) upsized & oversubscribed $550,000,000 Follow-On Offering, which priced at $85 per share.

https://t.co/tQFpZgQ6XF

[James Ahern @JamesPAhern]

2/3 Laidlaw is responsible for taking the company public as the Sole Book Runner on Viking’s $27,600,000 IPO, priced at $8 per share.

[James Ahern @JamesPAhern]

Great event last week with our partners at @Harvard
and @MassGeneralNews. We are pleased to announce $5.88 Million Award from U.S. DoD by our portfolio company Voltron Therapeutics
#CancerResearch #Cancer

[Antonio Grasso @antgrasso]

High inflation, slow growth, or a Japan-style bubble are all possible outcomes for the global economy. To protect ourselves, it is crucial to raise productivity and stimulate growth.

Source @McKinsey Link https://t.co/pT88QMD6sn via @antgrasso #CEO #COO

[James Ahern @JamesPAhern]

“It’s clear to see that the future of AR and VR in healthcare is bright, with continued advancements in software and hardware systems driving growth. As these technologies are proven to have benefits for immersive learning and patient…” — @JamesPAhern https://t.co/kWyAdvrmfe

[Mass General Brigham Research @MGBResearchNews]

Researchers from @MassGeneralNews and colleagues are learning from the gut microbiome to identify new cancer immunotherapies, in a @nature study. https://t.co/zGjnfafiBM

[Cingulate @CingulateInc]

Today we announced the successful manufacturing of CTx-1301 doses for both of our upcoming pivotal Phase 3 trials in pediatric and adolescents with #ADHD, with the fixed-dose study scheduled to begin the week of July 24.

Learn more: https://t.co/RlcNQZFKVo
$CING

[Ann Marie Sastry @annmariesastry]

Hope this helps! We are asked all the time about how to navigate digital integration. Tips here. Thanks to the team for getting this out for our Customers and partners! #educationforall #ArtificialIntelligence #GPT4 $AMST

[James Ahern @JamesPAhern]

One of Laidlaw's long-standing clients, Biosig Technologies, has showcased its brand-new technology at the Mayo Clinic 2023 Quality Conference. Proud to be part of their journey!
https://t.co/3VW4aQC9i7

[MassGeneral News @MassGeneralNews]

Research led by Christopher Hartnick, MD, and @brianskotko has proven the safety and efficacy of using hypoglossal nerve stimulation to treat obstructive sleep apnea in children with #DownSyndrome. https://t.co/9YQ3eGBytd

[McKinsey & Company @McKinsey]

These are the ten rules of value-creating #growth 📈

Which one is the most vital?

Learn more: https://t.co/DyTcC4CHyw

[Silo Pharma Inc. @SiloPharma]

Silo Pharma's New #Ketamine Implant For #Fibromyalgia And Chronic Pain Is In The Making.

Thank you @Benzinga for featuring our recent news. Read more here: https://t.co/meFeXjhLBq $SILO #PsychedelicResearch #Psychedelics

[James Ahern @JamesPAhern]

#Wearables offer huge opportunities in medicine and healthcare, they monitor vital signs, upload data to cloud in real time, and raise alerts, such as an irregular heartbeat. They literally have the potential to save lives.
#healthcareinvestment
https://t.co/iIMwCqgZhc

[James Ahern @JamesPAhern]

#AI is already making an impact in healthcare training and is reshaping the methods and efficiency of learning for healthcare professionals
#healthcaretraining
https://t.co/7XtUkBiGNY

[Ronald van Loon @Ronald_vanLoon]

Neuromorphic systems and evolutionary #AI
by @SpencerAcain @siemenssoftware

Read more: https://t.co/ysCCpg3ppk

#BigData #MachineLearning #ArtificialIntelligence #ML #MI #DataScience #Algorithm

cc: @ronald_vanloon @yvesmulkers @mikequindazzi